Literature DB >> 1536267

Update on the dementia spectrum of depression.

V O Emery1, T E Oxman.   

Abstract

OBJECTIVE: The primary focus of this review is to examine the usual dichotomy between depressive dementia as functional and reversible and degenerative dementia as organic and irreversible.
METHOD: The authors propose viewing depression, cognitive impairment, and degenerative dementia as intersecting continua. They define five prototypical groups along these continua: 1) major depression without depressive dementia, 2) depressive dementia, 3) degenerative dementia without depression, 4) depression of degenerative dementia, and 5) independent co-occurrence of degenerative dementia and depression. Clinical, neuropsychological, and neurobiological studies comparing these groupings were identified by a computerized literature search covering the past 20 years. References were selected for review if they compared at least two groups. Degenerative dementia was limited to the Alzheimer type.
RESULTS: No studies clearly included all five of the prototypical groups. There are methodological problems with each type of research reviewed, but the consensus of the research is that severe cognitive impairment of depression is associated with a variety of organic abnormalities. Depending on the length of follow-up, depressive dementia may not be as reversible as previously thought.
CONCLUSIONS: The continuum viewpoint encourages longitudinal clinical follow-up for early detection and alleviation of incipient depressive and dementing symptoms. Hypotheses of overlapping pathophysiological mechanisms rather than differential diagnosis become an important research focus. The authors discuss three different types of relationships for future research: 1) interactions, 2) consequences of disease or treatment, and 3) necessary but not sufficient pathophysiology.

Entities:  

Mesh:

Year:  1992        PMID: 1536267     DOI: 10.1176/ajp.149.3.305

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  11 in total

1.  Alzheimer disease: are we intervening too late? Pro.

Authors:  Virginia Olga B Emery
Journal:  J Neural Transm (Vienna)       Date:  2011-06-07       Impact factor: 3.575

2.  Regional cortical thickness and subcortical volume changes are associated with cognitive impairments in the drug-naive patients with late-onset depression.

Authors:  Hyun Kook Lim; Won Sang Jung; Kook Jin Ahn; Wang Youn Won; Changtae Hahn; Seung Yup Lee; Inseong Kim; Chang Uk Lee
Journal:  Neuropsychopharmacology       Date:  2011-11-02       Impact factor: 7.853

Review 3.  Depression in old age. Is there a real decrease in prevalence? A review.

Authors:  C Ernst; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

4.  Neurological signs and late-life depressive symptoms in a community population: the ESPRIT study.

Authors:  Mishael Soremekun; Robert Stewart; Florence Portet; Sylvaine Artero; Marie-Laure Ancelin; Karen Ritchie
Journal:  Int J Geriatr Psychiatry       Date:  2010-07       Impact factor: 3.485

Review 5.  Diffusion tensor imaging in Alzheimer's disease and affective disorders.

Authors:  Stefan J Teipel; Martin Walter; Yuttachai Likitjaroen; Peter Schönknecht; Oliver Gruber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-03-05       Impact factor: 5.270

Review 6.  CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease.

Authors:  K Blennow; E Vanmechelen; H Hampel
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.682

7.  Phenotypic Association Analyses With Copy Number Variation in Recurrent Depressive Disorder.

Authors:  James J H Rucker; Katherine E Tansey; Margarita Rivera; Dalila Pinto; Sarah Cohen-Woods; Rudolf Uher; Katherine J Aitchison; Nick Craddock; Michael J Owen; Lisa Jones; Ian Jones; Ania Korszun; Michael R Barnes; Martin Preisig; Ole Mors; Wolfgang Maier; John Rice; Marcella Rietschel; Florian Holsboer; Anne E Farmer; Ian W Craig; Stephen W Scherer; Peter McGuffin; Gerome Breen
Journal:  Biol Psychiatry       Date:  2015-02-25       Impact factor: 13.382

Review 8.  Peripheral Inflammatory Parameters in Late-Life Depression: A Systematic Review.

Authors:  Mónica Martínez-Cengotitabengoa; Lucía Carrascón; John T O'Brien; María-José Díaz-Gutiérrez; Cristina Bermúdez-Ampudia; Kenji Sanada; Marta Arrasate; Ana González-Pinto
Journal:  Int J Mol Sci       Date:  2016-12-02       Impact factor: 5.923

9.  Statins Reduces the Risk of Dementia in Patients with Late-Onset Depression: A Retrospective Cohort Study.

Authors:  Ya-Hsu Yang; Hao-Wei Teng; Yen-Ting Lai; Szu-Yuan Li; Chih-Ching Lin; Albert C Yang; Hsiang-Lin Chan; Yi-Hsuan Hsieh; Chiao-Fan Lin; Fu-Ying Hsu; Chih-Kuang Liu; Wen-Sheng Liu
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

10.  Utility of the Neurobehavioral Cognitive Status Examination (COGNISTAT) in differentiating between depressive states in late-life depression and late-onset Alzheimer's disease: a preliminary study.

Authors:  Yoshiaki Tsuruoka; Michio Takahashi; Masatoshi Suzuki; Koichi Sato; Yukihiko Shirayama
Journal:  Ann Gen Psychiatry       Date:  2016-01-20       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.